RECURRENT OVARY CANCER
Clinical trials for RECURRENT OVARY CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARY CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OVARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cells trained to fight ovarian cancer in new trial
Disease control Recruiting nowThis early-phase trial tests a new type of immune cell therapy called CIML NK cells in 18 people with recurrent ovarian cancer that no longer responds to standard chemotherapy. The cells are taken from the patient, trained in a lab to better attack cancer, and then infused into t…
Matched conditions: RECURRENT OVARY CANCER
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo targets tough ovarian cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called DT2216 combined with the chemotherapy paclitaxel in people whose ovarian cancer has returned and is resistant to platinum-based treatments. The main goal is to find the highest safe dose of DT2216 when given with paclitaxel. About 30…
Matched conditions: RECURRENT OVARY CANCER
Phase: PHASE1 • Sponsor: Elizabeth Stover, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC